WA
www.anosia-bio.com
The company develops novel T cell vaccines using patented adjuvants to enhance T cell immunity against cancer. This approach enables more effective immunotherapy options for patients facing various types of cancer.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The company develops novel T cell vaccines using patented adjuvants to enhance T cell immunity against cancer. This approach enables more effective immunotherapy options for patients facing various types of cancer.